An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

Mise à jour : Il y a 4 ans
Référence : NCT00744757

Femme et Homme

Extrait

The purpose of this study is to evaluate the response rate of decitabine in previously treated and untreated Taiwanese participants with Myelodysplastic Syndrome (MDS - a disease associated with decreased production of blood cells, blood cells are produced but do not mature normally).


Critère d'inclusion

  • myelodysplastic syndrome

Liens